Track Our Clinical Research

Pancreatic Cancer

Contact: CancerResearch@VirginiaMason.org or (206) 287-6270

Clinical Studies	Diagnosis
Clinical Studies	Non-Metastatic	Metastatic	Previously Treated	Treatment Naive
Alternating neoadjuvant Gemcitabine-Nab-Paclitaxel and na1-IRI with 5-Fluorouracil and folinic acid (Leucovorin) regimens in resectable and borderline resectable pancreatic cancer, A Pilot Study	✔			✔
Gemcitabine and nab-paclitaxel in pancreatic adenocarcinoma with positive peritoneal cytology as a sole metastatic site	✔			✔
Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)		✔		✔
Distal pancreatectomy, minimally invasive or open, for malignancy (DIPLOMA) – a randomized controlled trial	✔			✔
A Phase 3, Randomized, Double-Blind Study of Pamrevlumab or Placebo in combination with Gemcitabine Plus Nab-paclitaxel as Neoadjuvant Treatment in Patients with Locally Advanced, Unresectable Pancreatic Cancer		✔		✔
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs	✔	✔	✔	✔
Precision Promise Platform Trial For Metastatic Pancreatic Cancer	✔	✔	✔	✔
VM BRITE: A Cancer Registry and Specimen Repository to Support Future Research Projects	✔	✔	✔	✔